logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Benefitrisk Assessment In Pharmaceutical Research And Development Andreas Sashegyi

  • SKU: BELL-4738490
Benefitrisk Assessment In Pharmaceutical Research And Development Andreas Sashegyi
$ 31.00 $ 45.00 (-31%)

4.4

52 reviews

Benefitrisk Assessment In Pharmaceutical Research And Development Andreas Sashegyi instant download after payment.

Publisher: Taylor and Francis
File Extension: PDF
File size: 4.3 MB
Pages: 214
Author: Andreas Sashegyi, James Felli and Rebecca Noel
ISBN: 9781439867952, 143986795X
Language: English
Year: 2013

Product desciption

Benefitrisk Assessment In Pharmaceutical Research And Development Andreas Sashegyi by Andreas Sashegyi, James Felli And Rebecca Noel 9781439867952, 143986795X instant download after payment.

Many practitioners in the pharmaceutical industry are still largely unfamiliar with benefit-risk assessment, despite its growing prominence in drug development and commercialization. Helping to alleviate this knowledge gap, Benefit-Risk Assessment in Pharmaceutical Research and Development provides a succinct overview of the key considerations relevant to benefit-risk assessment across the pharmaceutical R&D spectrum, from early clinical development to late-stage development to regulatory review to post-launch assessment.The book first presents interpretations. 
Front Cover; Contents; Editors; Contributors; Prologue; Chapter 1: Pharmaceutical Benefit-Risk Assessment in Early Development; Chapter 2: Key Questions, Issues, and Challenges in Benefit-Risk Assessment in Full Clinical Development; Chapter 3: The Clinical Aspects of Benefit and Risk; Chapter 4: Quantifying Patient Preferences to Inform Benefit-Risk Evaluations; Chapter 5: Benefit-Risk Modeling of Medicinal Products: Methods and Applications; Chapter 6: Benefit-Risk Communication: Learning from Our Past and Creating Our Future Chapter 7: Policy Considerations and Strategic Issues Regarding Benefit-RiskChapter 8: Systematic Approaches to Benefit-Risk Assessment; Chapter 9: Considerations and Strategies for Benefit-Risk Assessment in the Real-World Setting; Chapter 10: Benefit-Risk Assessment and the Payer Perspective; Epilogue; Glossary; Back Cover

Related Products